SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001354488-16-007960
Filing Date
2016-07-01
Accepted
2016-07-01 09:02:13
Documents
1
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT issuerdirect_section16.html 4  
1 PRIMARY DOCUMENT issuerdirect_section16.xml 4 4069
  Complete submission text file 0001354488-16-007960.txt   5779
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Issuer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1100 LOUISIANA, SUITE 5250 HOUSTON TX 77002
Business Address (713) 652-6600
Seaman Scott B (Reporting) CIK: 0001359850 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33004 | Film No.: 161744866